what's difference between semaglutide and tirzepatide vs. Tirzepatide: Which GLP-1 Is Right for You? Comparative safety and side effects

In June 2023, the FDA issued a warning that unapproved versions of GLP-1 drugs "can be risky for patients, as unapproved versions do not undergo FDAs review for safety, effectiveness and quality before they are marketed." The GLP-1 drug market has been dominated by pharmaceutical giant Novo Nordisk

Ghrelin mediates anticipation to a palatable meal in rats

The body may have established new patterns that require gentle redirection rather than forceful intervention

Patients get it with an injectable pen and prefilled doses

Our goal is to see whether there is a differential impact on brain function from these drugs, depending on where you are in your neurodevelopmental trajectory. Turning to social media Some GLP-1 users have turned to social media to share their own experiences with food noise, shining a light on the cultural aspects of the phenomenon